Eli Lilly and Company raised earnings guidance for the year 2024. For the year, the company expects revenue of $42.4 billion to $43.6 billion against previous guidance of $40.4 billion to $41.6 billion. Earnings per Share (reported) of $13.05 to $13.55 against previous guidance of $11.80 to $12.30.